Literature DB >> 27027913

Respiratory gating for proton beam scanning versus photon 3D-CRT for breast cancer radiotherapy.

Anna M Flejmer1, Anneli Edvardsson2, Frida Dohlmar3, Dan Josefsson3, Mats Nilsson4, Petra Witt Nyström5, Alexandru Dasu3.   

Abstract

Background Respiratory gating and proton therapy have both been proposed to reduce the cardiopulmonary burden in breast cancer radiotherapy. This study aims to investigate the additional benefit of proton radiotherapy for breast cancer with and without respiratory gating. Material and methods Twenty left-sided patients were planned on computed tomography (CT)-datasets acquired during enhanced inspiration gating (EIG) and free-breathing (FB), using photon three-dimensional conformal radiation therapy (3D-CRT) and scanned proton beams. Ten patients received treatment to the whole breast only (WBO) and 10 were treated to the breast and the regional lymph nodes (BRN). Dosimetric parameters characterizing the coverage of target volumes and the cardiopulmonary burden were compared using a paired, two-tailed Student's t-test. Results Protons ensured comparable or better target coverage than photons in all patients during both EIG and FB. The heterogeneity index decreased from 12% with photons to about 5% with protons. The mean dose to the ipsilateral lung was reduced in BRN patients from 12 Gy to 7 Gy  (RBE) in EIG and from 14 Gy to 6-7 Gy (RBE) in FB, while for WBO patients all values were about 5-6 Gy (RBE). The mean dose to heart decreased by a factor of four in WBO patients [from 1.1 Gy to 0.3 Gy (RBE) in EIG and from 2.1 Gy to 0.5 Gy (RBE) in FB] and 10 in BRN patients [from 2.1 Gy to 0.2 Gy (RBE) in EIG and from 3.4 Gy to 0.3 Gy (RBE) in FB]. Similarly, the mean and the near maximum dose to the left anterior descending artery (LAD) were significantly lower (p < 0.05) with protons in comparison with photons. Conclusion Proton spot scanning has a high potential to reduce the irradiation of organs at risk and other normal tissues for most patients, beyond what could be achieved with EIG and photon therapy. The largest dose sparing has been seen for BRN patients, both in terms of cardiopulmonary burden and integral dose.

Entities:  

Mesh:

Year:  2016        PMID: 27027913     DOI: 10.3109/0284186X.2015.1120883

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  9 in total

1.  Proton reirradiation for recurrent or new primary breast cancer in the setting of prior breast irradiation.

Authors:  J Isabelle Choi; Atif J Khan; Simon N Powell; Beryl McCormick; Alicia J Lozano; Gabriely Del Rosario; Jacqueline Mamary; Haoyang Liu; Pamela Fox; Erin Gillespie; Lior Z Braunstein; Dennis Mah; Oren Cahlon
Journal:  Radiother Oncol       Date:  2021-10-22       Impact factor: 6.901

Review 2.  Dosimetric evaluation and systematic review of radiation therapy techniques for early stage node-negative breast cancer treatment.

Authors:  Tabitha Y Chan; Johann I Tang; Poh Wee Tan; Neill Roberts
Journal:  Cancer Manag Res       Date:  2018-10-23       Impact factor: 3.989

Review 3.  Proton beam therapy for cancer in the era of precision medicine.

Authors:  Man Hu; Liyang Jiang; Xiangli Cui; Jianguang Zhang; Jinming Yu
Journal:  J Hematol Oncol       Date:  2018-12-12       Impact factor: 17.388

4.  Selection criteria for early breast cancer patients in the DBCG proton trial - The randomised phase III trial strategy.

Authors:  Line Bjerregaard Stick; Ebbe Laugaard Lorenzen; Esben Svitzer Yates; Carmel Anandadas; Karen Andersen; Cynthia Aristei; Orla Byrne; Sandra Hol; Ingelise Jensen; Anna M Kirby; Youlia M Kirova; Livia Marrazzo; Angela Matías-Pérez; Mette Marie Bruun Nielsen; Henrik Dahl Nissen; Sileida Oliveros; Karolien Verhoeven; Johan Vikström; Birgitte Vrou Offersen
Journal:  Clin Transl Radiat Oncol       Date:  2021-02-04

Review 5.  Target motion management in breast cancer radiation therapy.

Authors:  Elham Piruzan; Naser Vosoughi; Seied Rabi Mahdavi; Leila Khalafi; Hojjat Mahani
Journal:  Radiol Oncol       Date:  2021-10-08       Impact factor: 2.991

Review 6.  Particle Therapy for Breast Cancer.

Authors:  Roman O Kowalchuk; Kimberly S Corbin; Rachel B Jimenez
Journal:  Cancers (Basel)       Date:  2022-02-20       Impact factor: 6.639

7.  Radiation-Induced Toxicity Risks in Photon Versus Proton Therapy for Synchronous Bilateral Breast Cancer.

Authors:  Line Bjerregaard Stick; Maria Fuglsang Jensen; Søren M Bentzen; Claus Kamby; Anni Young Lundgaard; Maja Vestmø Maraldo; Birgitte Vrou Offersen; Jen Yu; Ivan Richter Vogelius
Journal:  Int J Part Ther       Date:  2021-11-11

Review 8.  Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee.

Authors:  Robert W Mutter; J Isabelle Choi; Rachel B Jimenez; Youlia M Kirova; Marcio Fagundes; Bruce G Haffty; Richard A Amos; Julie A Bradley; Peter Y Chen; Xuanfeng Ding; Antoinette M Carr; Leslie M Taylor; Mark Pankuch; Raymond B Mailhot Vega; Alice Y Ho; Petra Witt Nyström; Lisa A McGee; James J Urbanic; Oren Cahlon; John H Maduro; Shannon M MacDonald
Journal:  Int J Radiat Oncol Biol Phys       Date:  2021-05-25       Impact factor: 8.013

Review 9.  The role of proton beam therapy in the management of elderly breast cancer patients.

Authors:  Benjamin J Rich; David Asher; Bosco Giap; Huan Giap
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.